Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006259 |
ID: | TCMBANKHE006259 |
植物拉丁名: |
|
功能与主治: | 1. Treatment of phlegm-heat cough manifested as cough with thick yellow sputum, asthma, chest pain and hypochondriac pain. Sea clam shell (Haigeke) is used with Costazia bone (Haifushi), Swallowwort rhizome (Baiqian), Mulberry bark (Sangbaipi), Capejasmine (Zhizi) and Trichosanthes fruit (Gualou). 2. Treatment of scrofula and goiter. Sea clam shell (Haigeke) is used with Laminaria (Kunbu), Seaweed (Haizao) and Ark shell (Walengzi) in the formula Hanhua Wan.3.Treatment of cough, chest pain and bloody sputum caused by heat in the lung, scrofula, goitre, epigastric pain associated with acid regurgitation, external use for eczema and scalds./1. Treatment of phlegm-heat cough manifested as cough with thick yellow sputum, asthma, chest pain and hypochondriac pain. Sea clam shell (Haigeke) is used with Costazia bone (Haifushi), Swallowwort rhizome (Baiqian), Mulberry bark (Sangbaipi), Capejasmin.2.Treatment of cough, chest pain and bloody sputum caused by heat in the lung, scrofula, goitre, epigastric pain associated with acid regurgitation, external use for eczema and scalds. |
药用植物名: | 海蛤壳;蛤壳 |
药用部位: | Meretrix meretrix Linnaeus.;Cyclina sinensis Gmelin |
药味: | Bitter; salty; cold |
经络: | Lung; stomach |
治疗类型: | 化痰止咳平喘 |
TCM_ID_id: | 1036;5570 |
TCMSP_id: | 957;274 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN004261 | Magnesium oxide | MgO | 40.305 g/mol | [O-2].[Mg+2] | |
| TCMBANKIN005990 | L-Phenylalanine | C9H11NO2 | 165.19 g/mol | C1=CC=C(C=C1)CC(C(=O)O)N | |
| TCMBANKIN012801 | docosahexaenoic acid | DHA; docosahexaenoic acid | C7H10O8 | 222.15 g/mol | C1C(C(C(OC1(C(=O)O)O)C(=O)O)O)O |
| TCMBANKIN018398 | l-aspartic acid | KB-259355; LT03328317; L-Aspartic acid, potassium salt (1:1); potassium 3-azanyl-4-oxidanyl-4-oxidanylidene-butanoate; AKOS016010461; RL05814; kaliumhydrogenaspartat; DL-Aspartic acid potassium salt; l-asparticacid; EINECS 213-088-2; J-002598; Potassium hydrogen DL-aspartate; AX8148812; BG00906804; Potassium 3-amino-3-carboxypropanoate; L-Aspartic acid, potassium salt (1:?); AK117181; 923-09-1; potassium 3-amino-4-hydroxy-4-oxobutanoate; X5496; A844192; L-Aspartic acid, potassium salt; FT-0625443; C4H6KNO4 | C4H6KNO4 | 171.19 g/mol | C(C(C(=O)O)N)C(=O)[O-].[K+] |
| TCMBANKIN018806 | conchiolin | C21H26O6 | 0 | CC=C(C)C(=O)OC1CC(=CCCC(=CC2C1C(=C)C(=O)O2)C)C(=O)OC | |
| TCMBANKIN020250 | Ethernet for Plant Automation | ||||
| TCMBANKIN030511 | l-arginine | (2S)-N-[(1S)-1-[[(1S)-1-(acetylcarbamoyl)-4-guanidino-butyl]carbamoyl]-4-guanidino-butyl]-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-hydroxy-pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanamide | C56H112N36O11 | 1465.7 g/mol | CC(=O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)O |
| TCMBANKIN031076 | Aluminium oxide | Al2O3 | 101.961 g/mol | [O-2].[O-2].[O-2].[Al+3].[Al+3] | |
| TCMBANKIN032731 | calcium oxide | CaO | 56.08 g/mol | [O-2].[Ca+2] | |
| TCMBANKIN035219 | magnesium carbonate | MgCO3? nH2O | 84.31 g/mol | C(=O)([O-])[O-].[Mg+2] | |
| TCMBANKIN035904 | calcium phosphate | Calipharm T; 915772-79-1; beta tricalcium phosphate; Calcium phosphates; alpha-Tricalcium phosphate; KSC377C4P; UNII-279O8I0433 component QORWJWZARLRLPR-UHFFFAOYSA-H; AC1Q22HV; 1269629-39-1; Synthos; Phosphoric acid calcium(2+) salt (2:3); Calcium phosphate, Reagent for transient & stable DNA transfections; 1344-15-6; EINECS 233-283-6; JAX TCP; Posture (TN); Multifos; Calcium phosphate tribasic; 12167-74-7 (tri-calcium salt); DB11348; AC1LANN3; Tricalcium phosphate hydrate; Ca3(PO4)2; tricalciumphosphate; MolPort-003-925-398; Tricalcium diphosphate; Tribasic calcium phosphate; UNII-K4C08XP666; Posture (calcium supplement); Calcium phosphate, purum p.a., >=96.0% (calc. as Ca3(PO4)2, KT); Cerasorb; 97Z1WI3NDX; bone phosphate; CCRIS 3668; Natural whitlockite; Caswell No. 148; beta-tri-Calcium phosphate, puriss. p.a., >=95% beta-phase basis (sintered powder); Bonarka; Synthograft; Ca3O8P2; 21063-37-6; FEMA No. 3081; AC1L2NG3; Ceredex; Tertiary calcium phosphate; calcium phosphate basic; 7758-87-4; EPA Pesticide Chemical Code 076401; 123211-19-8; C08136; alpha-TCP; CTK2H7147; AKOS015833108; Calcium orthophosphate; Calcium Phosphate Tribasic, Powder, Reagent; TR-024786; FT-0645103; Tricafos P; 1314234-39-3; 10103-46-5; alpha-tri-Calcium phosphate, Reagent for transient & stable DNA transfections; Phosphoric acid, calcium salt (2:3); Phosphoric acid, calcium salt; Calcium phosphate; Calcium phosphate tribasic 500g; Bone ash; K4C08XP666; BONE POWDER, PURIFIED; TricOs; tricalcium bis(phosphate); Calcium orthophosphate, tri-(tert); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (sintered Powder); CS-0013475; AI3-25607; alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder); 7757-93-9 (CaHPO4); CHEBI:9679; Calcium phosphate, tribasic; Tricalcium orthophosphate; OSferion; Vitoss; TRICALCIUM PHOSPHATE; tert-Calcium phosphate; 21063-37-6 (monetite); LS-2435; RTR-024786; tri-Calcium (ortho)phosphate; Calcigenol simple; tri-calcium phosphate; Tricalcium bis(orthophosphate); CHEMBL2106566; 1160697-13-1; Calcium phosphate (3:2); DTXSID1049803; Tricalcium phosphate hydrate, nanopowder, <200 nm particle size (BET); EC 231-840-8; D00938; Tricalcium bis(orthophosphate), with a fluorine content of less than 0,005 % by weight on the dry anhydrous product; beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (unsintered powder); Tricalcium phosphate (Ca3(PO4)2); Calcium tertiary phosphate; UNII-97Z1WI3NDX; Hydroxyapatite Powder; S338; Calcium phosphate (Ca3(PO4)2); beta-Tricalcium phosphate; KS-000011AF; beta-TCP; Ostram; beta-tri-Calcium phosphate, >=95% beta-phase basis (unsintered powder); calcium-phosphate; HSDB 879; QORWJWZARLRLPR-UHFFFAOYSA-H; EINECS 231-840-8; Phosphoric acid, calcium salt (1:?) | Ca5(PO4)3?OH or Ca3(PO4)2 | 310.2 g/mol | [O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2] |
| TCMBANKIN057923 | glycin | Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY | C2H5NO2 | 75.07 g/mol | C(C(=O)O)N |
| TCMBANKIN057988 | taurine | N-propyl-4-[5,10,13,14-tetramethyl-3,7,12-tris(oxidanyl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]butanamide; A801680; N-propyl-4-(3,7,12-trihydroxy-5,10,13,14-tetramethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanamide | C2H7NO3S | 125.15 g/mol | C(CS(=O)(=O)O)N |
| TCMBANKIN059137 | valine | C5H11NO2 | 117.15 g/mol | CC(C)C(C(=O)O)N | |
| TCMBANKIN061951 | fe2o3 | Iron(III)oxide;γ--Hiroki mellow | Fe2O3 | 159.69 g/mol | O=[Fe]O[Fe]=O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab